Staging disease severity in movement disorder tauopathies: Brain atrophy separates progressive supranuclear palsy from corticobasal degeneration
Identifieur interne : 003722 ( Main/Curation ); précédent : 003721; suivant : 003723Staging disease severity in movement disorder tauopathies: Brain atrophy separates progressive supranuclear palsy from corticobasal degeneration
Auteurs : Emma C. Schofield [Australie] ; Diana Caine [Australie] ; Jillian J. Kril [Australie] ; Nicholas J. Cordato [Australie] ; Glenda M. Halliday [Australie]Source :
- Movement Disorders [ 0885-3185 ] ; 2005-01.
Descripteurs français
- Pascal (Inist)
English descriptors
- KwdEn :
- Aged, Aged, 80 and over, Atrophy, Basal Ganglia Diseases (metabolism), Basal Ganglia Diseases (pathology), Chi-Square Distribution, Degeneration, Encephalon, Female, Follow-Up Studies, Humans, Male, Middle Aged, Nerve Degeneration (classification), Nerve Degeneration (metabolism), Nerve Degeneration (physiopathology), Nervous system diseases, Prospective Studies, Supranuclear Palsy, Progressive (metabolism), Supranuclear Palsy, Progressive (pathology), atrophy, corticobasal degeneration, progressive supranuclear palsy, staging, tau Proteins (metabolism), tauopathy.
- MESH :
- chemical , metabolism : tau Proteins.
- classification : Nerve Degeneration.
- metabolism : Basal Ganglia Diseases, Nerve Degeneration, Supranuclear Palsy, Progressive.
- pathology : Basal Ganglia Diseases, Supranuclear Palsy, Progressive.
- physiopathology : Nerve Degeneration.
- Aged, Aged, 80 and over, Atrophy, Chi-Square Distribution, Female, Follow-Up Studies, Humans, Male, Middle Aged, Prospective Studies.
Abstract
The movement disorders progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD) both deposit tau in degenerating neurons and are considered to be tauopathies. The recently developed scheme for staging tissue degeneration in another tauopathy, frontotemporal dementia [Broe et al., Neurology 2003;60:1005–1011] was applied to pathologically confirmed PSP (n = 24) and CBD (n = 9) cases and correlated with clinical indices. In contrast to frontotemporal dementia, the majority of PSP cases had limited or no visible atrophy, while the pattern of atrophy in CBD cases conformed to the existing staging scheme (all but one case exhibiting substantial visible tissue atrophy). Despite similar clinical severity and disease duration between groups, there was a marked difference between the PSP and CBD cases in pathological disease stage (χ2 = 8.86; P = 0.03). The degree of global atrophy in PSP appears to be distinct from other tauopathies, while CBD fits the same pattern as other pathological forms of frontotemporal dementia. © 2004 Movement Disorder Society
Url:
DOI: 10.1002/mds.20286
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001D76
- to stream Istex, to step Curation: Pour aller vers cette notice dans l'étape Curation :001D76
- to stream Istex, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :002128
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :003230
- to stream PubMed, to step Curation: Pour aller vers cette notice dans l'étape Curation :003230
- to stream PubMed, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :002F54
- to stream Ncbi, to step Merge: Pour aller vers cette notice dans l'étape Curation :001058
- to stream Ncbi, to step Curation: Pour aller vers cette notice dans l'étape Curation :001058
- to stream Ncbi, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :001058
- to stream Main, to step Merge: Pour aller vers cette notice dans l'étape Curation :004E05
- to stream PascalFrancis, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001F41
- to stream PascalFrancis, to step Curation: Pour aller vers cette notice dans l'étape Curation :000D80
- to stream PascalFrancis, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :001D07
- to stream Main, to step Merge: Pour aller vers cette notice dans l'étape Curation :005185
Links to Exploration step
ISTEX:9F073D1FCDB3A7E66F3982825948EC8631FD9849Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Staging disease severity in movement disorder tauopathies: Brain atrophy separates progressive supranuclear palsy from corticobasal degeneration</title>
<author><name sortKey="Schofield, Emma C" sort="Schofield, Emma C" uniqKey="Schofield E" first="Emma C." last="Schofield">Emma C. Schofield</name>
</author>
<author><name sortKey="Caine, Diana" sort="Caine, Diana" uniqKey="Caine D" first="Diana" last="Caine">Diana Caine</name>
</author>
<author><name sortKey="Kril, Jillian J" sort="Kril, Jillian J" uniqKey="Kril J" first="Jillian J." last="Kril">Jillian J. Kril</name>
</author>
<author><name sortKey="Cordato, Nicholas J" sort="Cordato, Nicholas J" uniqKey="Cordato N" first="Nicholas J." last="Cordato">Nicholas J. Cordato</name>
</author>
<author><name sortKey="Halliday, Glenda M" sort="Halliday, Glenda M" uniqKey="Halliday G" first="Glenda M." last="Halliday">Glenda M. Halliday</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:9F073D1FCDB3A7E66F3982825948EC8631FD9849</idno>
<date when="2005" year="2005">2005</date>
<idno type="doi">10.1002/mds.20286</idno>
<idno type="url">https://api.istex.fr/document/9F073D1FCDB3A7E66F3982825948EC8631FD9849/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001D76</idno>
<idno type="wicri:Area/Istex/Curation">001D76</idno>
<idno type="wicri:Area/Istex/Checkpoint">002128</idno>
<idno type="wicri:doubleKey">0885-3185:2005:Schofield E:staging:disease:severity</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:15390131</idno>
<idno type="wicri:Area/PubMed/Corpus">003230</idno>
<idno type="wicri:Area/PubMed/Curation">003230</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002F54</idno>
<idno type="wicri:Area/Ncbi/Merge">001058</idno>
<idno type="wicri:Area/Ncbi/Curation">001058</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001058</idno>
<idno type="wicri:doubleKey">0885-3185:2005:Schofield E:staging:disease:severity</idno>
<idno type="wicri:Area/Main/Merge">004E05</idno>
<idno type="wicri:source">INIST</idno>
<idno type="RBID">Pascal:05-0173684</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">001F41</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000D80</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">001D07</idno>
<idno type="wicri:doubleKey">0885-3185:2005:Schofield E:staging:disease:severity</idno>
<idno type="wicri:Area/Main/Merge">005185</idno>
<idno type="wicri:Area/Main/Curation">003722</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Staging disease severity in movement disorder tauopathies: Brain atrophy separates progressive supranuclear palsy from corticobasal degeneration</title>
<author><name sortKey="Schofield, Emma C" sort="Schofield, Emma C" uniqKey="Schofield E" first="Emma C." last="Schofield">Emma C. Schofield</name>
<affiliation wicri:level="1"><country xml:lang="fr">Australie</country>
<wicri:regionArea>Prince of Wales Medical Research Institute and the University of New South Wales, Randwick</wicri:regionArea>
<wicri:noRegion>Randwick</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Caine, Diana" sort="Caine, Diana" uniqKey="Caine D" first="Diana" last="Caine">Diana Caine</name>
<affiliation wicri:level="1"><country xml:lang="fr">Australie</country>
<wicri:regionArea>Department of Psychology, The University of Sydney, Camperdown</wicri:regionArea>
<wicri:noRegion>Camperdown</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Kril, Jillian J" sort="Kril, Jillian J" uniqKey="Kril J" first="Jillian J." last="Kril">Jillian J. Kril</name>
<affiliation wicri:level="1"><country xml:lang="fr">Australie</country>
<wicri:regionArea>Centre for Education and Research on Ageing, The University of Sydney, Concord Hospital, Concord</wicri:regionArea>
<wicri:noRegion>Concord</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Cordato, Nicholas J" sort="Cordato, Nicholas J" uniqKey="Cordato N" first="Nicholas J." last="Cordato">Nicholas J. Cordato</name>
<affiliation wicri:level="1"><country xml:lang="fr">Australie</country>
<wicri:regionArea>Department of Geriatric Medicine, Westmead Hospital and The University of Sydney, Westmead</wicri:regionArea>
<wicri:noRegion>Westmead</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Halliday, Glenda M" sort="Halliday, Glenda M" uniqKey="Halliday G" first="Glenda M." last="Halliday">Glenda M. Halliday</name>
<affiliation wicri:level="1"><country xml:lang="fr">Australie</country>
<wicri:regionArea>Prince of Wales Medical Research Institute and the University of New South Wales, Randwick</wicri:regionArea>
<wicri:noRegion>Randwick</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2005-01">2005-01</date>
<biblScope unit="vol">20</biblScope>
<biblScope unit="issue">1</biblScope>
<biblScope unit="page" from="34">34</biblScope>
<biblScope unit="page" to="39">39</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">9F073D1FCDB3A7E66F3982825948EC8631FD9849</idno>
<idno type="DOI">10.1002/mds.20286</idno>
<idno type="ArticleID">MDS20286</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term>
<term>Aged, 80 and over</term>
<term>Atrophy</term>
<term>Basal Ganglia Diseases (metabolism)</term>
<term>Basal Ganglia Diseases (pathology)</term>
<term>Chi-Square Distribution</term>
<term>Degeneration</term>
<term>Encephalon</term>
<term>Female</term>
<term>Follow-Up Studies</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Nerve Degeneration (classification)</term>
<term>Nerve Degeneration (metabolism)</term>
<term>Nerve Degeneration (physiopathology)</term>
<term>Nervous system diseases</term>
<term>Prospective Studies</term>
<term>Supranuclear Palsy, Progressive (metabolism)</term>
<term>Supranuclear Palsy, Progressive (pathology)</term>
<term>atrophy</term>
<term>corticobasal degeneration</term>
<term>progressive supranuclear palsy</term>
<term>staging</term>
<term>tau Proteins (metabolism)</term>
<term>tauopathy</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>tau Proteins</term>
</keywords>
<keywords scheme="MESH" qualifier="classification" xml:lang="en"><term>Nerve Degeneration</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>Basal Ganglia Diseases</term>
<term>Nerve Degeneration</term>
<term>Supranuclear Palsy, Progressive</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Basal Ganglia Diseases</term>
<term>Supranuclear Palsy, Progressive</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Nerve Degeneration</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Aged</term>
<term>Aged, 80 and over</term>
<term>Atrophy</term>
<term>Chi-Square Distribution</term>
<term>Female</term>
<term>Follow-Up Studies</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Prospective Studies</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Atrophie</term>
<term>Dégénérescence</term>
<term>Encéphale</term>
<term>Système nerveux pathologie</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="fr">The movement disorders progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD) both deposit tau in degenerating neurons and are considered to be tauopathies. The recently developed scheme for staging tissue degeneration in another tauopathy, frontotemporal dementia [Broe et al., Neurology 2003;60:1005–1011] was applied to pathologically confirmed PSP (n = 24) and CBD (n = 9) cases and correlated with clinical indices. In contrast to frontotemporal dementia, the majority of PSP cases had limited or no visible atrophy, while the pattern of atrophy in CBD cases conformed to the existing staging scheme (all but one case exhibiting substantial visible tissue atrophy). Despite similar clinical severity and disease duration between groups, there was a marked difference between the PSP and CBD cases in pathological disease stage (χ2 = 8.86; P = 0.03). The degree of global atrophy in PSP appears to be distinct from other tauopathies, while CBD fits the same pattern as other pathological forms of frontotemporal dementia. © 2004 Movement Disorder Society</div>
</front>
</TEI>
<double idat="0885-3185:2005:Schofield E:staging:disease:severity"><INIST><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Staging disease severity in movement disorder tauopathies: Brain atrophy separates progressive supranuclear palsy from corticobasal degeneration</title>
<author><name sortKey="Schofield, Emma C" sort="Schofield, Emma C" uniqKey="Schofield E" first="Emma C." last="Schofield">Emma C. Schofield</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Prince of Wales Medical Research Institute and the University of New South Wales</s1>
<s2>Randwick</s2>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<wicri:noRegion>Prince of Wales Medical Research Institute and the University of New South Wales</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Caine, Diana" sort="Caine, Diana" uniqKey="Caine D" first="Diana" last="Caine">Diana Caine</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Department of Psychology, The University of Sydney</s1>
<s2>Camperdown</s2>
<s3>AUS</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<wicri:noRegion>Camperdown</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Kril, Jillian J" sort="Kril, Jillian J" uniqKey="Kril J" first="Jillian J." last="Kril">Jillian J. Kril</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Centre for Education and Research on Ageing, The University of Sydney, Concord Hospital</s1>
<s2>Concord</s2>
<s3>AUS</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<wicri:noRegion>Concord</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Cordato, Nicholas J" sort="Cordato, Nicholas J" uniqKey="Cordato N" first="Nicholas J." last="Cordato">Nicholas J. Cordato</name>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Department of Geriatric Medicine, Westmead Hospital and The University of Sydney</s1>
<s2>Westmead</s2>
<s3>AUS</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<wicri:noRegion>Westmead</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Halliday, Glenda M" sort="Halliday, Glenda M" uniqKey="Halliday G" first="Glenda M." last="Halliday">Glenda M. Halliday</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Prince of Wales Medical Research Institute and the University of New South Wales</s1>
<s2>Randwick</s2>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<wicri:noRegion>Prince of Wales Medical Research Institute and the University of New South Wales</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">05-0173684</idno>
<date when="2005">2005</date>
<idno type="stanalyst">PASCAL 05-0173684 INIST</idno>
<idno type="RBID">Pascal:05-0173684</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">001F41</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000D80</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">001D07</idno>
<idno type="wicri:doubleKey">0885-3185:2005:Schofield E:staging:disease:severity</idno>
<idno type="wicri:Area/Main/Merge">005185</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Staging disease severity in movement disorder tauopathies: Brain atrophy separates progressive supranuclear palsy from corticobasal degeneration</title>
<author><name sortKey="Schofield, Emma C" sort="Schofield, Emma C" uniqKey="Schofield E" first="Emma C." last="Schofield">Emma C. Schofield</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Prince of Wales Medical Research Institute and the University of New South Wales</s1>
<s2>Randwick</s2>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<wicri:noRegion>Prince of Wales Medical Research Institute and the University of New South Wales</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Caine, Diana" sort="Caine, Diana" uniqKey="Caine D" first="Diana" last="Caine">Diana Caine</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Department of Psychology, The University of Sydney</s1>
<s2>Camperdown</s2>
<s3>AUS</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<wicri:noRegion>Camperdown</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Kril, Jillian J" sort="Kril, Jillian J" uniqKey="Kril J" first="Jillian J." last="Kril">Jillian J. Kril</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Centre for Education and Research on Ageing, The University of Sydney, Concord Hospital</s1>
<s2>Concord</s2>
<s3>AUS</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<wicri:noRegion>Concord</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Cordato, Nicholas J" sort="Cordato, Nicholas J" uniqKey="Cordato N" first="Nicholas J." last="Cordato">Nicholas J. Cordato</name>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Department of Geriatric Medicine, Westmead Hospital and The University of Sydney</s1>
<s2>Westmead</s2>
<s3>AUS</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<wicri:noRegion>Westmead</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Halliday, Glenda M" sort="Halliday, Glenda M" uniqKey="Halliday G" first="Glenda M." last="Halliday">Glenda M. Halliday</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Prince of Wales Medical Research Institute and the University of New South Wales</s1>
<s2>Randwick</s2>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<wicri:noRegion>Prince of Wales Medical Research Institute and the University of New South Wales</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="2005">2005</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Atrophy</term>
<term>Degeneration</term>
<term>Encephalon</term>
<term>Nervous system diseases</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Système nerveux pathologie</term>
<term>Encéphale</term>
<term>Atrophie</term>
<term>Dégénérescence</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The movement disorders progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD) both deposit tau in degenerating neurons and are considered to be tauopathies. The recently developed scheme for staging tissue degeneration in another tauopathy, frontotemporal dementia [Broe et al., Neurology 2003;60:1005-1011] was applied to pathologically confirmed PSP (n = 24) and CBD (n = 9) cases and correlated with clinical indices. In contrast to frontotemporal dementia, the majority of PSP cases had limited or no visible atrophy, while the pattern of atrophy in CBD cases conformed to the existing staging scheme (all but one case exhibiting substantial visible tissue atrophy). Despite similar clinical severity and disease duration between groups, there was a marked difference between the PSP and CBD cases in pathological disease stage (X<sup>2</sup>
= 8.86; P = 0.03). The degree of global atrophy in PSP appears to be distinct from other tauopathies, while CBD fits the same pattern as other pathological forms of frontotemporal dementia.</div>
</front>
</TEI>
</INIST>
<ISTEX><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Staging disease severity in movement disorder tauopathies: Brain atrophy separates progressive supranuclear palsy from corticobasal degeneration</title>
<author><name sortKey="Schofield, Emma C" sort="Schofield, Emma C" uniqKey="Schofield E" first="Emma C." last="Schofield">Emma C. Schofield</name>
</author>
<author><name sortKey="Caine, Diana" sort="Caine, Diana" uniqKey="Caine D" first="Diana" last="Caine">Diana Caine</name>
</author>
<author><name sortKey="Kril, Jillian J" sort="Kril, Jillian J" uniqKey="Kril J" first="Jillian J." last="Kril">Jillian J. Kril</name>
</author>
<author><name sortKey="Cordato, Nicholas J" sort="Cordato, Nicholas J" uniqKey="Cordato N" first="Nicholas J." last="Cordato">Nicholas J. Cordato</name>
</author>
<author><name sortKey="Halliday, Glenda M" sort="Halliday, Glenda M" uniqKey="Halliday G" first="Glenda M." last="Halliday">Glenda M. Halliday</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:9F073D1FCDB3A7E66F3982825948EC8631FD9849</idno>
<date when="2005" year="2005">2005</date>
<idno type="doi">10.1002/mds.20286</idno>
<idno type="url">https://api.istex.fr/document/9F073D1FCDB3A7E66F3982825948EC8631FD9849/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001D76</idno>
<idno type="wicri:Area/Istex/Curation">001D76</idno>
<idno type="wicri:Area/Istex/Checkpoint">002128</idno>
<idno type="wicri:doubleKey">0885-3185:2005:Schofield E:staging:disease:severity</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:15390131</idno>
<idno type="wicri:Area/PubMed/Corpus">003230</idno>
<idno type="wicri:Area/PubMed/Curation">003230</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002F54</idno>
<idno type="wicri:Area/Ncbi/Merge">001058</idno>
<idno type="wicri:Area/Ncbi/Curation">001058</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001058</idno>
<idno type="wicri:doubleKey">0885-3185:2005:Schofield E:staging:disease:severity</idno>
<idno type="wicri:Area/Main/Merge">004E05</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Staging disease severity in movement disorder tauopathies: Brain atrophy separates progressive supranuclear palsy from corticobasal degeneration</title>
<author><name sortKey="Schofield, Emma C" sort="Schofield, Emma C" uniqKey="Schofield E" first="Emma C." last="Schofield">Emma C. Schofield</name>
<affiliation wicri:level="1"><country xml:lang="fr">Australie</country>
<wicri:regionArea>Prince of Wales Medical Research Institute and the University of New South Wales, Randwick</wicri:regionArea>
<wicri:noRegion>Randwick</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Caine, Diana" sort="Caine, Diana" uniqKey="Caine D" first="Diana" last="Caine">Diana Caine</name>
<affiliation wicri:level="1"><country xml:lang="fr">Australie</country>
<wicri:regionArea>Department of Psychology, The University of Sydney, Camperdown</wicri:regionArea>
<wicri:noRegion>Camperdown</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Kril, Jillian J" sort="Kril, Jillian J" uniqKey="Kril J" first="Jillian J." last="Kril">Jillian J. Kril</name>
<affiliation wicri:level="1"><country xml:lang="fr">Australie</country>
<wicri:regionArea>Centre for Education and Research on Ageing, The University of Sydney, Concord Hospital, Concord</wicri:regionArea>
<wicri:noRegion>Concord</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Cordato, Nicholas J" sort="Cordato, Nicholas J" uniqKey="Cordato N" first="Nicholas J." last="Cordato">Nicholas J. Cordato</name>
<affiliation wicri:level="1"><country xml:lang="fr">Australie</country>
<wicri:regionArea>Department of Geriatric Medicine, Westmead Hospital and The University of Sydney, Westmead</wicri:regionArea>
<wicri:noRegion>Westmead</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Halliday, Glenda M" sort="Halliday, Glenda M" uniqKey="Halliday G" first="Glenda M." last="Halliday">Glenda M. Halliday</name>
<affiliation wicri:level="1"><country xml:lang="fr">Australie</country>
<wicri:regionArea>Prince of Wales Medical Research Institute and the University of New South Wales, Randwick</wicri:regionArea>
<wicri:noRegion>Randwick</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2005-01">2005-01</date>
<biblScope unit="vol">20</biblScope>
<biblScope unit="issue">1</biblScope>
<biblScope unit="page" from="34">34</biblScope>
<biblScope unit="page" to="39">39</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">9F073D1FCDB3A7E66F3982825948EC8631FD9849</idno>
<idno type="DOI">10.1002/mds.20286</idno>
<idno type="ArticleID">MDS20286</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term>
<term>Aged, 80 and over</term>
<term>Atrophy</term>
<term>Basal Ganglia Diseases (metabolism)</term>
<term>Basal Ganglia Diseases (pathology)</term>
<term>Chi-Square Distribution</term>
<term>Female</term>
<term>Follow-Up Studies</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Nerve Degeneration (classification)</term>
<term>Nerve Degeneration (metabolism)</term>
<term>Nerve Degeneration (physiopathology)</term>
<term>Prospective Studies</term>
<term>Supranuclear Palsy, Progressive (metabolism)</term>
<term>Supranuclear Palsy, Progressive (pathology)</term>
<term>atrophy</term>
<term>corticobasal degeneration</term>
<term>progressive supranuclear palsy</term>
<term>staging</term>
<term>tau Proteins (metabolism)</term>
<term>tauopathy</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>tau Proteins</term>
</keywords>
<keywords scheme="MESH" qualifier="classification" xml:lang="en"><term>Nerve Degeneration</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>Basal Ganglia Diseases</term>
<term>Nerve Degeneration</term>
<term>Supranuclear Palsy, Progressive</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Basal Ganglia Diseases</term>
<term>Supranuclear Palsy, Progressive</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Nerve Degeneration</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Aged</term>
<term>Aged, 80 and over</term>
<term>Atrophy</term>
<term>Chi-Square Distribution</term>
<term>Female</term>
<term>Follow-Up Studies</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Prospective Studies</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="fr">The movement disorders progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD) both deposit tau in degenerating neurons and are considered to be tauopathies. The recently developed scheme for staging tissue degeneration in another tauopathy, frontotemporal dementia [Broe et al., Neurology 2003;60:1005–1011] was applied to pathologically confirmed PSP (n = 24) and CBD (n = 9) cases and correlated with clinical indices. In contrast to frontotemporal dementia, the majority of PSP cases had limited or no visible atrophy, while the pattern of atrophy in CBD cases conformed to the existing staging scheme (all but one case exhibiting substantial visible tissue atrophy). Despite similar clinical severity and disease duration between groups, there was a marked difference between the PSP and CBD cases in pathological disease stage (χ2 = 8.86; P = 0.03). The degree of global atrophy in PSP appears to be distinct from other tauopathies, while CBD fits the same pattern as other pathological forms of frontotemporal dementia. © 2004 Movement Disorder Society</div>
</front>
</TEI>
</ISTEX>
</double>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003722 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Curation/biblio.hfd -nk 003722 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= Main |étape= Curation |type= RBID |clé= ISTEX:9F073D1FCDB3A7E66F3982825948EC8631FD9849 |texte= Staging disease severity in movement disorder tauopathies: Brain atrophy separates progressive supranuclear palsy from corticobasal degeneration }}
This area was generated with Dilib version V0.6.23. |